JP2023529371A5 - - Google Patents
Info
- Publication number
- JP2023529371A5 JP2023529371A5 JP2022574541A JP2022574541A JP2023529371A5 JP 2023529371 A5 JP2023529371 A5 JP 2023529371A5 JP 2022574541 A JP2022574541 A JP 2022574541A JP 2022574541 A JP2022574541 A JP 2022574541A JP 2023529371 A5 JP2023529371 A5 JP 2023529371A5
- Authority
- JP
- Japan
- Prior art keywords
- dnaj
- fusion protein
- synuclein
- group
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026066932A JP2026120714A (ja) | 2020-06-05 | 2026-04-15 | シヌクレイノパチーの処置のための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063035297P | 2020-06-05 | 2020-06-05 | |
| US63/035,297 | 2020-06-05 | ||
| PCT/US2021/035958 WO2021248038A1 (en) | 2020-06-05 | 2021-06-04 | Compositions and methods for the treatment of synucleinopathies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066932A Division JP2026120714A (ja) | 2020-06-05 | 2026-04-15 | シヌクレイノパチーの処置のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023529371A JP2023529371A (ja) | 2023-07-10 |
| JP2023529371A5 true JP2023529371A5 (cg-RX-API-DMAC7.html) | 2024-06-10 |
| JP7887366B2 JP7887366B2 (ja) | 2026-07-09 |
Family
ID=76708439
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574541A Active JP7887366B2 (ja) | 2020-06-05 | 2021-06-04 | シヌクレイノパチーの処置のための組成物および方法 |
| JP2026066932A Pending JP2026120714A (ja) | 2020-06-05 | 2026-04-15 | シヌクレイノパチーの処置のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066932A Pending JP2026120714A (ja) | 2020-06-05 | 2026-04-15 | シヌクレイノパチーの処置のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230234997A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4161953A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7887366B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116096737B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3183251A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021248038A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024026284A2 (en) * | 2022-07-25 | 2024-02-01 | Interius Biotherapeutics, Inc. | Mutated polypeptides, compositions comprising the same, and uses thereof |
| WO2024229777A1 (zh) * | 2023-05-11 | 2024-11-14 | 深圳先进技术研究院 | 一种aav载体及其应用 |
| CN116590342B (zh) * | 2023-05-11 | 2026-04-03 | 普递瑞(上海)医药有限公司 | 一种aav载体及其应用 |
| CN117402251B (zh) * | 2023-12-15 | 2024-02-23 | 中国医学科学院基础医学研究所 | 一种抗小g蛋白rbj的抗体及其应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8918616D0 (en) | 1989-08-15 | 1989-09-27 | Univ Glasgow | Herpes simplex virus type 1 mutant |
| US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| EP1002119A1 (en) | 1997-07-31 | 2000-05-24 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Targeted hsv vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| DE69939169D1 (de) | 1998-05-28 | 2008-09-04 | Us Gov Health & Human Serv | Aav5 vektoren und deren verwendung |
| CN1246532A (zh) * | 1998-08-31 | 2000-03-08 | 复旦大学 | 人热休克关联蛋白编码序列、其编码的多肽及制备方法 |
| US7465583B2 (en) | 2000-06-01 | 2008-12-16 | The University Of North Carolina At Chapel Hill | Duplexed parvovirus vectors |
| CN1440420A (zh) * | 2000-07-07 | 2003-09-03 | 万能药制药公司 | 预防神经组织损伤和治疗α-共核蛋白疾病的方法 |
| WO2002053703A2 (en) | 2001-01-05 | 2002-07-11 | Children's Hospital, Inc. | Aav2 vectors and methods |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| EP1668143B1 (en) | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| EP1828390B1 (en) | 2004-12-15 | 2012-06-13 | The University Of North Carolina At Chapel Hill | Chimeric vectors |
| WO2008002465A2 (en) * | 2006-06-23 | 2008-01-03 | The Feinstein Institute For Medical Research | INHIBITORS OF Aβ AND SYNUCLEIN AGGREGATION |
| EP2396343B1 (en) | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| US9169494B2 (en) | 2010-01-12 | 2015-10-27 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
| WO2011097456A2 (en) | 2010-02-05 | 2011-08-11 | The University Of North Carolina At Chapel Hill | Compositions and methods for enhanced parvovirus transduction |
| WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| EP2929045B1 (en) * | 2012-12-05 | 2020-12-02 | SOLA Biosciences LLC | Protein expression enhancing polypeptides |
| WO2018058088A1 (en) * | 2016-09-26 | 2018-03-29 | SOLA Biosciences, LLC | Cell-associated secretion-enhancing fusion proteins |
| WO2019161386A1 (en) | 2018-02-19 | 2019-08-22 | New York University | Alpha-synuclein single domain antibodies |
| WO2021138582A1 (en) * | 2019-12-31 | 2021-07-08 | The Johns Hopkins University | Fusion proteins and methods of use thereof |
-
2021
- 2021-06-04 US US18/007,978 patent/US20230234997A1/en active Pending
- 2021-06-04 CN CN202180058141.7A patent/CN116096737B/zh active Active
- 2021-06-04 WO PCT/US2021/035958 patent/WO2021248038A1/en not_active Ceased
- 2021-06-04 JP JP2022574541A patent/JP7887366B2/ja active Active
- 2021-06-04 CA CA3183251A patent/CA3183251A1/en active Pending
- 2021-06-04 EP EP21736438.9A patent/EP4161953A1/en active Pending
-
2026
- 2026-04-15 JP JP2026066932A patent/JP2026120714A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2230569T3 (es) | Funciones accesorias para uso en la produccion de viriones aav recombinantes. | |
| JP2020522269A5 (cg-RX-API-DMAC7.html) | ||
| AU2018303230B2 (en) | Improved AAV capsid production in insect cells | |
| CA2985945C (en) | Capsid | |
| ES2703814T3 (es) | Terapia génica para la enfermedad de Fabry | |
| Lu | Recombinant adeno-associated virus as delivery vector for gene therapy—a review | |
| CA2418442C (en) | Novel helper functions for recombinant vector production | |
| ES2302331T3 (es) | Vectores que codifican genomas de aav recombinantes. | |
| US10413598B2 (en) | Factor IX gene therapy | |
| JP2023524414A5 (cg-RX-API-DMAC7.html) | ||
| US20170067028A1 (en) | Radiolabeling of adeno associated virus | |
| JP2022508182A5 (cg-RX-API-DMAC7.html) | ||
| JP2021512649A5 (cg-RX-API-DMAC7.html) | ||
| TW202005978A (zh) | 新穎肝靶向腺相關病毒載體 | |
| KR20160131032A (ko) | 곤충 세포에서 생산된 더욱 향상된 aav 벡터 | |
| TW201546285A (zh) | 腺相關病毒因子viii載體 | |
| JP2025069281A (ja) | 調節可能な発現系 | |
| JP7616668B2 (ja) | Ube3a遺伝子および発現カセットならびにそれらの使用 | |
| JP2024159800A (ja) | 筋肉発現のためのハイブリッドプロモーター | |
| JP2017529395A5 (cg-RX-API-DMAC7.html) | ||
| JP2023524024A5 (cg-RX-API-DMAC7.html) | ||
| JP2023520927A5 (cg-RX-API-DMAC7.html) | ||
| JP2023537358A5 (cg-RX-API-DMAC7.html) | ||
| JP2025513887A (ja) | 肝臓における遺伝子発現を脱標的化するための要素 | |
| US20240425879A1 (en) | Compositions and methods for adeno-associated (aav) virus dnase expression |